Safety of rilpivirine and boceprevir coadministration in HIV-infected patients treated for acute hepatitis C virus infection

Sebastiaan J. Hullegie; Brenda C. M. de Winter; Dirk Posthouwer; Peter P. Koopmans; Mark A. A. Claassen; David M. Burger; Bart J. A. Rijnders

doi:10.1097/QAD.0000000000000950

Safety of rilpivirine and boceprevir coadministration in HIV-infected patients treated for acute hepatitis C virus infection

Sebastiaan J. Hullegie^*, Brenda C. M. de Winter, Dirk Posthouwer, Peter P. Koopmans, Mark A. A. Claassen, David M. Burger, Bart J. A. Rijnders

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	529-530
Journal	Aids
Volume	30
Issue number	3
DOIs	https://doi.org/10.1097/QAD.0000000000000950
Publication status	Published - 28 Jan 2016

Access to Document

10.1097/QAD.0000000000000950

Cite this

@article{c2209cf8b87243678f5b1b2663270b89,

title = "Safety of rilpivirine and boceprevir coadministration in HIV-infected patients treated for acute hepatitis C virus infection",

author = "Hullegie, {Sebastiaan J.} and {de Winter}, {Brenda C. M.} and Dirk Posthouwer and Koopmans, {Peter P.} and Claassen, {Mark A. A.} and Burger, {David M.} and Rijnders, {Bart J. A.}",

year = "2016",

month = jan,

day = "28",

doi = "10.1097/QAD.0000000000000950",

language = "English",

volume = "30",

pages = "529--530",

journal = "Aids",

issn = "0269-9370",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "3",

}

TY - JOUR

T1 - Safety of rilpivirine and boceprevir coadministration in HIV-infected patients treated for acute hepatitis C virus infection

AU - Hullegie, Sebastiaan J.

AU - de Winter, Brenda C. M.

AU - Posthouwer, Dirk

AU - Koopmans, Peter P.

AU - Claassen, Mark A. A.

AU - Burger, David M.

AU - Rijnders, Bart J. A.

PY - 2016/1/28

Y1 - 2016/1/28

U2 - 10.1097/QAD.0000000000000950

DO - 10.1097/QAD.0000000000000950

M3 - Comment/Letter to the editor

SN - 0269-9370

VL - 30

SP - 529

EP - 530

JO - Aids

JF - Aids

IS - 3

ER -